Barclays PLC Novartis Ag Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$106.13 - $120.89 $12.5 Million - $14.2 Million	117,600 New	117,600 $13.5 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $831,050 - $1.02 Million	11,000 New	11,000 $998,000
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $8.38 Million - $9.89 Million	100,400 Added 512.24%	120,000 $10.3 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $172,494 - $191,100	-2,100 Reduced 9.68%	19,600 $1.7 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $5.24 Million - $5.89 Million	-64,700 Reduced 74.88%	21,700 $1.9 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $2.38 Million - $3.34 Million	-33,700 Reduced 28.06%	86,400 $7.12 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $2.81 Million - $3.18 Million	-33,300 Reduced 21.71%	120,100 $11.4 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $8.58 Million - $9.45 Million	100,300 Added 188.89%	153,400 $13.3 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $1.66 Million - $2.04 Million	22,000 Added 70.74%	53,100 $4.85 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $4.1 Million - $4.69 Million	-54,400 Reduced 63.63%	31,100 $2.99 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $5.52 Million - $6.15 Million	75,000 Added 714.29%	85,500 $7.34 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $274,454 - $317,463	-4,100 Reduced 28.08%	10,500 $905,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $1.22 Million - $1.38 Million	-18,800 Reduced 56.29%	14,600 $1.1 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $274,521 - $328,185	-3,900 Reduced 10.46%	33,400 $2.7 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $1.86 Million - $2 Million	25,700 Added 221.55%	37,300 $3.13 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $860,024 - $896,332	11,600	11,600 $996,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account